Thomas M Harrington
Overview
Explore the profile of Thomas M Harrington including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yahya T, Dhanyamraju S, Harrington T, Prichard J
Ann Clin Lab Sci
. 2013 Nov;
43(4):447-9.
PMID: 24247804
Introduction: Etanercept, a systemic inhibitor of α-TNF, is used for treatment of various autoimmune disorders. We report a case of spontaneous resolution of etanercept-induced lupus nephritis. Case Description: A 57-year-old...
2.
Antohe J, Delvecchio B, Harrington T
J Clin Rheumatol
. 2012 Mar;
18(3):162.
PMID: 22456522
No abstract available.
3.
Olenginski T, Antohe J, Sunderlin E, Harrington T
Rheumatol Int
. 2011 Nov;
32(11):3619-24.
PMID: 22101613
To evaluate physician response to dual-energy X-ray absorptiometry (DXA) report within the Geisinger Medical Center's Mobile DXA Program and treatment adherence at 1 year. Between 10/01/2004 and 3/30/2005, 1381 DXA...
4.
Ledwich L, Harrington T, Ayoub W, Sartorius J, Newman E
Arthritis Rheum
. 2009 Oct;
61(11):1505-10.
PMID: 19877088
Objective: To examine whether an electronic health record (EHR) best practice alert (BPA), a clinical reminder to help guideline adherence, improved vaccination rates in rheumatology patients receiving immunosuppressants. Guidelines recommend...
5.
Adhikesavan L, Harrington T
J Clin Rheumatol
. 2008 Jun;
14(3):156-60.
PMID: 18525435
Mycobacterium marinum is a free-living, nontuberculous, photochromogenic mycobacterium, which can cause opportunistic infections in humans. It can cause infection through the skin that has undergone minor trauma, as the portal...
6.
Bucaloiu I, Olenginski T, Harrington T
Mayo Clin Proc
. 2007 Dec;
82(12):1510-5.
PMID: 18053459
Objective: To review the clinical and laboratory features of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) in a rural tertiary care rheumatology practice, describe treatments and outcomes, and compare...
7.
Ramos J, Bush D, Harrington T
Orthopedics
. 2007 Mar;
30(3):239-40.
PMID: 17375553
No abstract available.
8.
Saripalli L, Harrington T, Notz R, Torretti D
J Clin Rheumatol
. 2005 Dec;
11(3):134-9.
PMID: 16357731
Objective: The objective of this study was to review the characteristics of patients with corneal melt and to assess if treatment with disease-modifying antirheumatic drugs (DMARDs) improved the visual outcome....
9.
Rich J, Bush D, Lincoski C, Harrington T
Orthopedics
. 2004 Sep;
27(8):862-3.
PMID: 15369009
Tophaceous gout is a recognized cause of carpal tunnel syndrome. Of 2649 carpal tunnel releases, 15 hands in 13 patients were identified with tophaceous gout in the carpal tunnel. The...
10.
Newman E, Harrington T, Olenginski T, Perruquet J, McKinley K
Arthritis Rheum
. 2004 Apr;
51(2):253-7.
PMID: 15077268
Objective: To provide rheumatologic care to patients in a timely and patient-centered manner. Methods: We developed and implemented processes to measure and help eliminate backlog, created access time for same-day...